Hansson O

Family name	Hansson
Given name	Oskar
Initials	O
ORCID	ORCID 0000-0001-8467-7286
Affiliations	Clinical Memory Research Unit, Lund University, Lund, Sweden. Memory Clinic, Skåne University Hospital, Malmö, Sweden.

21 publications

PubMed DOI Crossref

Author Correction: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.

Ali M, Erabadda B, Chen Y, ..., Winchester L, Cruchaga C

Nat. Med. 31 (10) 3569 [2025-10-00; online 2025-09-03]

PubMed DOI Crossref

Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes.

Boccalini C, Mathoux G, Hristovska I, ..., Vogel JW, Garibotto V

Neurology 105 (7) e213950 [2025-10-00; online 2025-09-12]

PubMed DOI Crossref

Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease.

Anijärv TE, Ossenkoppele R, Smith R, ..., Spotorno N, Hansson O

Nat Commun 16 (1) 8232 [2025-09-05; online 2025-09-05]

PubMed DOI Crossref

Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification.

Mastenbroek SE, Collij LE, Vogel JW, ..., Ossenkoppele R, Hansson O

Nat Commun 16 (1) 7182 [2025-08-05; online 2025-08-05]

PubMed DOI Crossref

The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.

Imam F, Saloner R, Vogel JW, ..., Lovestone S, Global Neurodegeneration Proteomics Consortium (GNPC)

Nat. Med. 31 (8) 2556-2566 [2025-08-00; online 2025-07-15]

PubMed DOI Crossref

Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.

Ali M, Erabadda B, Chen Y, ..., Winchester L, Cruchaga C

Nat. Med. 31 (8) 2567-2577 [2025-08-00; online 2025-07-15]

PubMed DOI Crossref

Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,170 people.

An L, Pichet-Binette A, Hristovska I, ..., Hansson O, Vogel JW

medRxiv - (-) - [2025-07-01; online 2025-07-01]

PubMed DOI Crossref

Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Saloner R, Staffaroni AM, Dammer EB, ..., Casaletto KB, ALLFTD Consortium

Nat Aging 5 (7) 1372 [2025-07-00; online 2025-07-08]

PubMed DOI Crossref

Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Saloner R, Staffaroni AM, Dammer EB, ..., Casaletto KB, ALLFTD Consortium

Nat Aging 5 (6) 1143-1158 [2025-06-00; online 2025-05-16]

PubMed DOI Crossref

Proteomic changes in Alzheimer's disease associated with progressive Aβ plaque and tau tangle pathologies.

Pichet Binette A, Gaiteri C, Wennström M, ..., Vogel JW, Hansson O

Nat. Neurosci. 27 (10) 1880-1891 [2024-10-00; online 2024-08-26]

DDLS Fellow Jacob W Vogel

PubMed DOI Crossref

A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.

Baumeister H, Vogel JW, Insel PS, ..., Hansson O, Berron D

Brain 147 (7) 2400-2413 [2024-07-05; online 2024-04-24]

DDLS Fellow Jacob W Vogel

PubMed DOI Crossref

Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.

Mastenbroek SE, Vogel JW, Collij LE, ..., Beach TG, Hansson O

Nat Commun 15 (1) 5133 [2024-06-15; online 2024-06-15]

DDLS Fellow Jacob W Vogel

PubMed DOI Crossref

Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases.

Karlsson L, Vogel J, Arvidsson I, ..., Mattsson-Carlgren N, Hansson O

Nat Commun 15 (1) 3676 [2024-05-01; online 2024-05-01]

DDLS Fellow Jacob W Vogel

PubMed DOI Crossref

Disease staging of Alzheimer's disease using a CSF-based biomarker model.

Salvadó G, Horie K, Barthélemy NR, ..., Bateman RJ, Hansson O

Nat Aging 4 (5) 694-708 [2024-05-00; online 2024-03-21]

DDLS Fellow Jacob W Vogel

PubMed DOI Crossref

Biomarker-based staging of Alzheimer disease: rationale and clinical applications.

Therriault J, Schindler SE, Salvadó G, ..., Jack CR, Rosa-Neto P

Nat Rev Neurol 20 (4) 232-244 [2024-04-00; online 2024-03-01]

DDLS Fellow Jacob W Vogel

PubMed DOI Crossref

Is GBA1 T369M not a risk factor for Parkinson's disease in the Swedish population?

Brolin KA, Bäckström D, Wallenius J, ..., Hansson O, Swanberg M

medRxiv - (-) - [2024-03-16; online 2024-03-16]

PubMed DOI Crossref

Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.

Zhao JH, Stacey D, Eriksson N, ..., Butterworth AS, Peters JE

Nat. Immunol. 24 (11) 1960 [2023-11-00; online 2023-09-08]

PubMed DOI Crossref

The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases.

Smith R, Capotosti F, Schain M, ..., Streffer J, Hansson O

Nat Commun 14 (1) 6750 [2023-10-27; online 2023-10-27]

PubMed DOI Crossref

Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.

Zhao JH, Stacey D, Eriksson N, ..., Butterworth AS, Peters JE

Nat. Immunol. 24 (9) 1540-1551 [2023-09-00; online 2023-08-10]

DOI Crossref

Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases

Karlsson L, Vogel J, Arvidsson I, ..., Mattsson-Carlgren N, Hansson O

- - (-) - [2023-06-09; online 2023-06-09]

PubMed DOI Crossref

Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.

Young AL, Vogel JW, Robinson JL, ..., Lee EB, Hansson O

Brain - (-) - [2023-05-08; online 2023-05-08]

DDLS Fellow Jacob W Vogel